Key result
Loop diuretic up-titration is associated with a ~2.3 mm Hg drop in seated mPAP.
Why the study?
Does titration of heart failure medications predictably change seated mean pulmonary artery pressure during ambulatory hemodynamic monitoring in patients with heart failure?
Observational (n=456)
Does titration of heart failure medications predictably change seated mean pulmonary artery pressure during ambulatory hemodynamic monitoring in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Ambulatory hemodynamic monitoring using seated mean pulmonary artery pressure detects expected short-term hemodynamic responses to titrations of loop diuretics and ARNIs in heart failure patients.
INTRODUCTION: Ambulatory hemodynamic monitoring (AHM) of heart failure (HF) using pulmonary artery pressure (PAP) is marked by frequent changes in HF medications. We are beginning to learn how medication titrations during AHM affect mean PAP (mPAP) measured in the seated position, which reflects most waking hours. METHOD: We analyzed the 12-month data from the PROACTIVE-HF trial of the Cordella Cordella, Endotronix Inc, Naperville, Illinois, United States) PAP sensor system. Seated mPAP was examined in the 14-days before and after isolated changes in medications; only those medications with ≥10 titrations were analyzed. Dependent sample Wilcoxon-signed rank test was used to compare changes in mPAP with titrations. RESULTS: We analyzed 456 subjects (age: 64 years, females: 40%, Black: 18%, HF with reduced ejection fraction: 46%). Loop diuretics (LD) were up-titrated 176 times in 133 patients and down-titrated 113 times in 96 patients. Before LD up-titration, mPAP increased by 1.6 ± 1.0 mm Hg; afterwards, it decreased by 2.3 ± 1.0 mm Hg (P < 0.001), with most reduction occurring within 1 week. Down-titration of LD was followed by an increase of 1.8 ± 1.3 mm Hg (P = 0.004) over the next several days. Similar trends were observed across categories of ejection fraction (≤40% and >40%). Angiotensin receptor neprilysin inhibitor (ARNI) up-titration decreased mPAP by 1.8 ± 1.9 mm Hg (P = 0.042), whereas down-titration increased mPAP by 1.5 ± 1.4 (P = 0.094). Mineralocorticoid receptor antagonist (MRA) up-titration tended to decrease mPAP (1.6 ± 2.5 mm Hg, P = 0.286,) whereas down-titration was followed by a significant increase in mPAP of 3.2 ± 1.6 mm Hg (P = 0.001). CONCLUSION: The AHM platform using seated mPAP data provided valuable insights into its short-term responses to isolated changes in HF medications. The seated mPAP changed expectedly in response to the titration of LD, whereas the degree of response varied for ARNI and MRA. Ongoing investigation will further characterize the timing and variability of responses to inform algorithms for ambulatory management of PAP.
No takes yet. Share an insight, caveat, or question.
Zalawadiya et al. (2025) conducted an observational in Heart failure (n=456). Titration of heart failure medications (loop diuretics, ARNI, MRA) vs. Before titration (14-day baseline) was evaluated on Change in seated mean pulmonary artery pressure (mPAP) (Decrease of 2.3 mm Hg (for loop diuretic up-titration), p=<0.001). Up-titration of loop diuretics significantly decreased seated mean pulmonary artery pressure by 2.3 mm Hg (P<0.001), while down-titration increased it by 1.8 mm Hg (P=0.004).
Synapse has enriched 10 related papers. Consider them for comparative context: